Background: Fluid status is an independent predictor of mortality in dialysis patients. Current methods of fluid assessment have several limitations. Summary: An ideal method should be cheap, portable, easy to perform without extensive training, reproducible and determines patients' excess or deficit of total body water. Bioimpedance analysis (BIA) fulfils many of these criteria and can give additional information on fat and lean tissue composition. The accuracy and precision of BIA has been shown to be equivalent to the ‘gold standard' direct estimation techniques. Key Messages: Although there remains some concern about its validity in dialysis patients, fluid overload determined by BIA has been shown to predict mortality. BIA-guided fluid management appears superior to conventional fluid management in achieving clinically important outcomes such as reduction in blood pressure, left ventricular mass index, and arterial stiffness. Accurate setting of dry weight might also help preserve residual renal function by limiting episodes of dehydration. Nevertheless, as with all new technologies, there are issues that still need to be resolved. This will be achieved only with larger prospective interventional studies to explore its specific roles in dialysis cohorts.

Keywords:
Bioimpedance, Fluid overload, Volume assessment, Dialysis, Mortality, Fluid management, Clinical outcome
1.
Ozkahya M, et al: Long-term survival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 2006;21:3506-3513.
2.
Jaffrin MY, Morel H: Body fluid volumes measurements by impedance: a review of bioimpedance spectroscopy (BIS) and bioimpedance analysis (BIA) methods. Med Eng Phys 2008;30:1257-1269.
3.
Moissl UM, et al: Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas 2006;27:921-933.
4.
Chamney PW, et al: A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 2007;85:80-89.
5.
Kraemer M: A new model for the determination of fluid status and body composition from bioimpedance measurements. Physiol Meas 2006;27:901-919.
6.
Paniagua R, et al: NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients. Nephrol Dial Transplant 2010;25:551-557.
7.
Agarwal R: B-type natriuretic peptide is not a volume marker among patients on hemodialysis. Nephrol Dial Transplant 2013;28:3082-3089.
8.
Davenport A: Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients. Am J Nephrol 2012;36:371-376.
9.
Raimann JG, et al: Comparison of fluid volume estimates in chronic hemodialysis patients by bioimpedance, direct isotopic, and dilution methods. Kidney Int 2014;85:898-908.
10.
Passauer J, et al: Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy: a cross-sectional study. Nephrol Dial Transplant 2010;25:545-551.
11.
Wizemann V, et al: The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009;24:1574-1579.
12.
Chazot C, et al: Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant 2012;27:2404-2410.
13.
O'Lone EL, et al: Clinical significance of multi-frequency bioimpedance spectroscopy in peritoneal dialysis patients: independent predictor of patient survival. Nephrol Dial Transplant 2014;29:1430-1437.
14.
John B, et al: Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol 2010;5:1463-1470.
15.
Davies SJ, et al: Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange. Nephrol Dial Transplant 2008;23:2982-2988.
16.
Machek P, et al: Guided optimization of fluid status in haemodialysis patients. Nephrol Dial Transplant 2010;25:538-544.
17.
Moissl U, et al: Bioimpedance-guided fluid management in hemodialysis patients. Clin J Am Soc Nephrol 2013;8:1575-1582.
18.
Hur E, et al: Effect of fluid management guided by bioimpedance spectroscopy on cardiovascular parameters in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis 2013;61:957-965.
19.
Onofriescu M, et al: Bioimpedance-guided fluid management in maintenance hemodialysis: a pilot randomized controlled trial. Am J Kidney Dis 2014;64:111-118.
20.
McCafferty K, Fan S, Davenport A: Extracellular volume expansion, measured by multifrequency bioimpedance, does not help preserve residual renal function in peritoneal dialysis patients. Kidney Int 2014;85:151-157.
21.
Parmentier SP, et al: Influence of peritoneal dialysis solution on measurements of fluid status by bioimpedance spectroscopy. Int Urol Nephrol 2013;45:229-232.
22.
Sipahi S, et al: Body composition monitor measurement technique for the detection of volume status in peritoneal dialysis patients: the effect of abdominal fullness. Int Urol Nephrol 2011;43:1195-1199.
23.
Davenport A: Does peritoneal dialysate affect body composition assessments using multi-frequency bioimpedance in peritoneal dialysis patients? Eur J Clin Nutr 2013;67:223-225.
24.
Luo YJ, et al: Volume control in peritoneal dialysis patients guided by bioimpedance spectroscopy assessment. Blood Purif 2011;31:296-302.
25.
Fan S, Sayed RH, Davenport A: Extracellular volume expansion in peritoneal dialysis patients. Int J Artif Organs 2012;35:338-345.
26.
Gunal AI, et al: Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 2001;37:588-593.
27.
Burke SE, Fan SL: Clinical experience using bioimpedance to optimize blood pressure control. Perit Dial Int 2013;33:205-208.
28.
Hur E, et al: Bioimpedance and echocardiography used interchangeably in volume comparison of dialysis patients. Hippokratia 2012;16:329-334.
29.
Van Biesen W, et al: Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort. PLoS One 2011;6:e17148.
30.
Liu L, et al: Determination of fluid status in haemodialysis patients with whole body and calf bioimpedance techniques. Nephrology (Carlton) 2012;17:131-140.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.